NCT01102673
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
Clinical trial condition
Explore clinical trials studying Glucose Metabolism Disorders. Study availability and eligibility vary by location and protocol.
NCT01102673
NCT00095654
Not specified
NCT00221156
NCT00108615
NCT00464529
NCT00483769
NCT02710370
NCT02994459
NCT06295640
NCT04972955